Biomarkers found that could be drug targets against a deadly form of brain cancer
Biomarkers that could be targets for novel drugs to treat glioblastoma brain tumors have been identified, providing hope for a cancer that is highly lethal. This new finding provides early evidence that there may be a benefit in targeting specific alterations in cancer cells with newer agents once a patient’s tumor becomes resistant to temozolomide.
Materials provided by Georgetown University Medical Center. Note: Content may be edited for style and length.
Source link aaaaa
